COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,142 | +6.3% | 19,022 | +2.2% | 0.00% | +50.0% |
| Q2 2023 | $399,907 | -9.2% | 18,609 | +1.4% | 0.00% | -33.3% |
| Q1 2023 | $440,217 | +3.9% | 18,350 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $423,818 | +42.2% | 18,268 | -1.9% | 0.00% | +50.0% |
| Q3 2022 | $298,000 | -8.6% | 18,619 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $326,000 | -19.1% | 18,405 | -7.0% | 0.00% | 0.0% |
| Q1 2022 | $403,000 | +2.8% | 19,780 | -5.8% | 0.00% | 0.0% |
| Q4 2021 | $392,000 | -10.3% | 20,992 | -5.1% | 0.00% | 0.0% |
| Q3 2021 | $437,000 | -19.1% | 22,118 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $540,000 | -0.6% | 22,859 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $543,000 | +35.8% | 22,896 | +14.7% | 0.00% | +100.0% |
| Q4 2020 | $400,000 | -6.3% | 19,955 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $427,000 | +16.3% | 20,528 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $367,000 | +18.0% | 20,994 | +10.3% | 0.00% | 0.0% |
| Q1 2020 | $311,000 | -24.9% | 19,026 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $414,000 | +77.7% | 20,125 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $233,000 | -13.4% | 20,295 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $269,000 | -4.9% | 20,436 | +9.2% | 0.00% | 0.0% |
| Q1 2019 | $283,000 | -14.8% | 18,713 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $332,000 | +15.7% | 19,320 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $287,000 | -37.1% | 19,468 | +1.8% | 0.00% | -50.0% |
| Q2 2018 | $456,000 | +11.5% | 19,118 | +19.4% | 0.00% | +100.0% |
| Q1 2018 | $409,000 | +31.1% | 16,017 | -5.1% | 0.00% | 0.0% |
| Q4 2017 | $312,000 | +96.2% | 16,879 | +11.1% | 0.00% | 0.0% |
| Q3 2017 | $159,000 | -9.7% | 15,198 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $176,000 | +76.0% | 14,061 | +41.3% | 0.00% | – |
| Q1 2017 | $100,000 | -17.4% | 9,948 | +27.8% | 0.00% | – |
| Q4 2016 | $121,000 | -99.9% | 7,785 | -0.3% | 0.00% | -100.0% |
| Q3 2016 | $150,344,000 | +62.8% | 7,806 | +0.1% | 0.00% | – |
| Q2 2016 | $92,371,000 | +30.1% | 7,795 | +99.6% | 0.00% | – |
| Q1 2016 | $71,000,000 | -33.6% | 3,906 | 0.0% | 0.00% | – |
| Q4 2015 | $107,000,000 | +122888.5% | 3,906 | -0.2% | 0.00% | – |
| Q3 2015 | $87,000 | -99.9% | 3,913 | +0.1% | 0.00% | – |
| Q2 2015 | $69,737,000 | – | 3,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |